Author Details

Антонова, Татьяна Галяутдиновна

Issue	Section	Title	File
Vol 25, No 3 (2023)	CLINICAL ONCOLOGY	Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis	(Rus)
Vol 26, No 3 (2024)	Articles	The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study	(Rus)
Vol 26, No 3 (2024)	Articles	Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study	(Rus)
Vol 26, No 4 (2024)	Articles	First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx	(Rus)
Vol 27, No 1 (2025)	Articles	Efficacy and safety of immunotherapy for metastatic renal cell carcinoma: A retrospective study	(Rus)
Vol 27, No 3 (2025)	Articles	Development of diabetes mellitus on the background of immunotherapy in patients with malignant neoplasms: A retrospective study	(Rus)
Vol 27, No 3 (2025)	Articles	Safety and toxicity of first-line combination therapy in patients with advanced renal cell carcinoma: A real-world retrospective study	(Rus)
Vol 27, No 3 (2025)	Articles	Myelodysplastic syndrome during therapy with immune checkpoint inhibitors: A clinical case	(Rus)

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register